Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Ifetroban (DB12321)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03694249Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceTreatment